Retinoblastoma is a disease that affects the eye. It often presents at an early age and is, in fact, the most common intraocular cancer disease during childhood.
Currently, it represents 3% of all childhood cancers, with an incidence of 1 case per 15,000-18,000 live births. These figures translate to a total of 5,000 new cases worldwide each year, approximately.
Diagnosis of this disease occurs, on average, at 18 months of age. In addition, 90% of cases are usually detected in the first 5 years of life. There is no sex that is more affected, therefore, it affects boys and girls equally.
Although its origin is well known, the survival rate is around 86% – 92% worldwide, and close to 70% in still developing countries. What are your symptoms? What treatments are available? We will detail it below.
Causes of retinoblastoma
Retinoblastoma is an oncological disease associated with a gene mutation. This gene is known as the retinoblastoma gene. When we talk about the retinoblastoma gene, we are talking about the mutation of the long arm of chromosome 13.
One of the functions of chromosome 13 is the suppression of complex mechanisms of the retinal cellular system, through the RB1 gene. If both gene equivalent loci within chromosome 13 are affected, this causes retinoblastoma.
In less than 10% of cases of retinoblastoma there is a family history of this disease, although it is estimated that about 30% – 40% of all cases are hereditary.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy